Global Proteomics Markets to 2027 - Increasing Interest for Customized Drug Showcase -

DUBLIN--()--The "Global Proteomics Market Analysis & Trends - Industry Forecast to 2027" report has been added to's offering.

The Global Proteomics Market is poised to grow strong during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include government and private firm initiative for funding, increasing interest for customized drug showcase and rising R&D activities for proteomics.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
Report Highlights
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

1.1 Research Methodology

1.1.1 Research Approach & Sources

1.2 Market Trends

1.3 Regulatory Factors

1.4 Application Analysis

1.5 Strategic Benchmarking

1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Government and Private Firms Initiative for Funding

3.1.2 Increasing Interest for Customized Drug Showcase

3.1.3 Rising R&D Activities for Proteomics

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Proteomics Market, By Reagent

4.1 X-Ray Crystallography Reagents

4.2 Immunoassay Reagents

4.3 Protein Microarray Reagents

4.4 Protein Fractionation Reagents

4.5 Chromatography Reagents

4.6 Spectroscopy Reagents

4.7 Electrophoresis Reagents

4.8 Surface Plasma Resonance Systems

4.9 Other Reagents

5 Proteomics Market, By Instrumentation Technology

5.1 Surface Plasmon Resonance (SPR)

5.2 Protein Fractionation

5.3 X-Ray Crystallography

5.4 Spectroscopy

5.4.1 CD Spectroscopy

5.4.2 Mass Spectrometry

5.4.3 NMR Spectroscopy

5.5 Protein Microarrays

5.5.1 Microarray Instruments Microarray Scanners Arrayers Integrated Systems

5.5.2 Biochips Lab-On-Chips (Microfluidics) Protein Chips

5.6 Chromatography

5.6.1 Supercritical Fluid Chromatography

5.6.2 High-Performance Liquid Chromatography (HPLC)

5.6.3 Ion Chromatography

5.6.4 Affinity Chromatography

5.7 Electrophoresis

5.7.1 Capillary Electrophoresis

5.7.2 Gel Electrophoresis

6 Proteomics Market, By Services and Software

6.1 Data Analysis & Maintenance

6.1.1 Bioinformatics Tools

6.1.2 Bioinformatics Databases

6.2 Quantitation Services

6.3 Analytical Laboratory Services

6.3.1 Protein Sequencing

6.3.2 Protein Identification

6.3.3 Protein Separation

7 Proteomics Market, By Application

7.1 Clinical Diagnostics

7.2 Drug Discovery

7.3 Other Proteomics Applications

8 Proteomics Market, By Geography

8.1 North America

8.1.1 US

8.1.2 Canada

8.1.3 Mexico

8.2 Europe

8.2.1 Germany

8.2.2 U.K

8.2.3 Italy

8.2.4 France

8.2.5 Spain

8.2.6 Rest of Europe

8.3 Asia Pacific

8.3.1 China

8.3.2 Japan

8.3.3 India

8.3.4 Australia

8.3.5 New Zealand

8.3.6 Rest of Asia Pacific

8.4 Middle East

8.4.1 Saudi Arabia

8.4.2 UAE

8.4.3 Rest of Middle East

8.5 Latin America

8.5.1 Argentina

8.5.2 Brazil

8.5.3 Rest of Latin America

8.6 Rest of the World (RoW)

8.6.1 South Africa

8.6.2 Others

9 Key Player Activities

9.1 Acquisitions & Mergers

9.2 Agreements, Partnerships, Collaborations and Joint Ventures

9.3 Product Launch & Expansions

9.4 Other Activities

10 Leading Companies

10.1 Bruker Corporation

10.2 Perkinelmer, Inc.

10.3 Danaher Corporation

10.4 Thermo Fisher Scientific, Inc.

10.5 Bio-Rad Laboratories, Inc.

10.6 Agilent Technologies, Inc.

10.7 Merck KGaA

10.8 Luminex Corporation

10.9 Waters Corporation

10.10 General Electric Co.

10.11 Caprion Proteomics Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Proteomics

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Proteomics